These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4001739)

  • 1. Rubella vaccine in the People's Republic of China.
    Han YR; Zhao K; Gong YX; Hao SL; Wang SZ; Wang CT
    Rev Infect Dis; 1985; 7 Suppl 1():S79. PubMed ID: 4001739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Level of antibodies against rubella in the normal population of Nanning city and a survey of the immunizing efficacy of rubella live-vaccines].
    Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb; 6(1):12-4. PubMed ID: 3995568
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
    Freestone DS
    Dev Biol Stand; 1976; 33():237-40. PubMed ID: 782973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rubella outbreak investigation and BRD-II strain rubella vaccine effectiveness study, Harbin city, Heilongjiang province, China, 2010-2011.
    Xu H; Gao X; Bo F; Ma J; Li Y; Fan C; Jiang L; Ma Y; Luo H; An Z
    Vaccine; 2013 Dec; 32(1):85-9. PubMed ID: 24188756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the live attenuated rubella virus vaccine. III. Clinical trials with rubella virus (Takahashi strain) vaccine in children and women.
    Yamane Y; Nagashima T; Asahara T; Nagamine T; Kawakubo Y
    Kitasato Arch Exp Med; 1974 Sep; 47(3):89-100. PubMed ID: 4459505
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of RA27/3 rubella vaccine and clinical results with the vaccine.
    Plotkin SA; Beale AJ
    Dev Biol Stand; 1976 Dec 13-15; 37():291-6. PubMed ID: 1031691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetomaternal apects of immunization with RA27/3 live attenuated rubella virus vaccine during pregnancy.
    Bernstein DI; Ogra PL
    J Pediatr; 1980 Sep; 97(3):467-70. PubMed ID: 7411312
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on live rubella vaccine. 3. Field trials with vaccines attenuated by serial passages in primary pig kidney cells.
    Suzuki M; Minekawa Y; Osame J; Ueda S; Ogino T
    Biken J; 1973 Dec; 16(4):149-54. PubMed ID: 4799206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rubella screening in school girls using the radial hemolysis test and their vaccination with attenuated live vaccine of the RA23/3 strain].
    Strauss J; Benes C; Macátová I
    Z Gesamte Hyg; 1988 Oct; 34(10):589-91. PubMed ID: 3201803
    [No Abstract]   [Full Text] [Related]  

  • 12. [A serological study on the immunization schedule at first dose of domestic BRD II strain rubella vaccine].
    Xu AQ; Song LZ; Hao SZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Jun; 18(3):156-9. PubMed ID: 9812464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulations of rubella vaccination strategies in China.
    Gao L; Hethcote H
    Math Biosci; 2006 Aug; 202(2):371-85. PubMed ID: 16603207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rubella screening and directed vaccination of 14-year-old girls with live rubella vaccine RA 27/3 in the Liberec district].
    Strauss J; Zikmundová V; Stovicek Z; Zikmund V; Téminová V; Langhammer O; Kokesová O
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):266-76. PubMed ID: 6215992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An observation of the immuno-persistence after inoculating with the domestic BRD II strain rubella vaccine among infants and young children].
    Xu A; Song L; Wang C; Wang A; Xu Q; Xiao Z; Wang S; Li M; Hao S; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):117-20. PubMed ID: 11860770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines.
    Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P
    Dev Biol Stand; 1976 Dec 13-15; 37():297-300. PubMed ID: 1031692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine.
    Hillary IB; Griffith AH
    Br Med J; 1980 Jun; 280(6231):1580-1. PubMed ID: 7427177
    [No Abstract]   [Full Text] [Related]  

  • 20. Re-infection and congenital rubella syndrome.
    Ross R; Harvey DR; Hurley R
    Practitioner; 1992 Mar; 236(1512):246-51. PubMed ID: 1631004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.